Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16

Marie Pancera, Syed Shahzad-Ul-Hussan, Nicole A. Doria-Rose, Jason S. McLellan, Robert T. Bailer, Kaifan Dai, Sandra Loesgen, Mark K. Louder, Ryan P. Staupe, Yongping Yang, Baoshan Zhang, Robert Parks, Joshua Eudailey, Krissey E. Lloyd, Julie Blinn, S. Munir Alam, Barton F. Haynes, Mohammed N. Amin, Lai Xi Wang, Dennis R. BurtonWayne C. Koff, Gary J. Nabel, John R. Mascola, Carole A. Bewley, Peter D. Kwong

Research output: Contribution to journalArticle

Abstract

HIV-1 uses a diverse N-linked-glycan shield to evade recognition by antibody. Select human antibodies, such as the clonally related PG9 and PG16, recognize glycopeptide epitopes in the HIV-1 V1-V2 region and penetrate this shield, but their ability to accommodate diverse glycans is unclear. Here we report the structure of antibody PG16 bound to a scaffolded V1-V2, showing an epitope comprising both high mannose-type and complex-type N-linked glycans. We combined structure, NMR and mutagenesis analyses to characterize glycan recognition by PG9 and PG16. Three PG16-specific residues, arginine, serine and histidine (RSH), were critical for binding sialic acid on complex-type glycans, and introduction of these residues into PG9 produced a chimeric antibody with enhanced HIV-1 neutralization. Although HIV-1-glycan diversity facilitates evasion, antibody somatic diversity can overcome this and can provide clues to guide the design of modified antibodies with enhanced neutralization.

Original languageEnglish (US)
Pages (from-to)804-813
Number of pages10
JournalNature structural & molecular biology
Volume20
Issue number7
DOIs
StatePublished - Jul 2013
Externally publishedYes

Fingerprint

Polysaccharides
HIV-1
Antibodies
Epitopes
Antibody Diversity
Glycopeptides
N-Acetylneuraminic Acid
Mannose
Histidine
Mutagenesis
Serine
Arginine

ASJC Scopus subject areas

  • Structural Biology
  • Molecular Biology

Cite this

Pancera, M., Shahzad-Ul-Hussan, S., Doria-Rose, N. A., McLellan, J. S., Bailer, R. T., Dai, K., ... Kwong, P. D. (2013). Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16. Nature structural & molecular biology, 20(7), 804-813. https://doi.org/10.1038/nsmb.2600

Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16. / Pancera, Marie; Shahzad-Ul-Hussan, Syed; Doria-Rose, Nicole A.; McLellan, Jason S.; Bailer, Robert T.; Dai, Kaifan; Loesgen, Sandra; Louder, Mark K.; Staupe, Ryan P.; Yang, Yongping; Zhang, Baoshan; Parks, Robert; Eudailey, Joshua; Lloyd, Krissey E.; Blinn, Julie; Alam, S. Munir; Haynes, Barton F.; Amin, Mohammed N.; Wang, Lai Xi; Burton, Dennis R.; Koff, Wayne C.; Nabel, Gary J.; Mascola, John R.; Bewley, Carole A.; Kwong, Peter D.

In: Nature structural & molecular biology, Vol. 20, No. 7, 07.2013, p. 804-813.

Research output: Contribution to journalArticle

Pancera, M, Shahzad-Ul-Hussan, S, Doria-Rose, NA, McLellan, JS, Bailer, RT, Dai, K, Loesgen, S, Louder, MK, Staupe, RP, Yang, Y, Zhang, B, Parks, R, Eudailey, J, Lloyd, KE, Blinn, J, Alam, SM, Haynes, BF, Amin, MN, Wang, LX, Burton, DR, Koff, WC, Nabel, GJ, Mascola, JR, Bewley, CA & Kwong, PD 2013, 'Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16', Nature structural & molecular biology, vol. 20, no. 7, pp. 804-813. https://doi.org/10.1038/nsmb.2600
Pancera, Marie ; Shahzad-Ul-Hussan, Syed ; Doria-Rose, Nicole A. ; McLellan, Jason S. ; Bailer, Robert T. ; Dai, Kaifan ; Loesgen, Sandra ; Louder, Mark K. ; Staupe, Ryan P. ; Yang, Yongping ; Zhang, Baoshan ; Parks, Robert ; Eudailey, Joshua ; Lloyd, Krissey E. ; Blinn, Julie ; Alam, S. Munir ; Haynes, Barton F. ; Amin, Mohammed N. ; Wang, Lai Xi ; Burton, Dennis R. ; Koff, Wayne C. ; Nabel, Gary J. ; Mascola, John R. ; Bewley, Carole A. ; Kwong, Peter D. / Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16. In: Nature structural & molecular biology. 2013 ; Vol. 20, No. 7. pp. 804-813.
@article{2ae9569484474c44a27622549a7e9629,
title = "Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16",
abstract = "HIV-1 uses a diverse N-linked-glycan shield to evade recognition by antibody. Select human antibodies, such as the clonally related PG9 and PG16, recognize glycopeptide epitopes in the HIV-1 V1-V2 region and penetrate this shield, but their ability to accommodate diverse glycans is unclear. Here we report the structure of antibody PG16 bound to a scaffolded V1-V2, showing an epitope comprising both high mannose-type and complex-type N-linked glycans. We combined structure, NMR and mutagenesis analyses to characterize glycan recognition by PG9 and PG16. Three PG16-specific residues, arginine, serine and histidine (RSH), were critical for binding sialic acid on complex-type glycans, and introduction of these residues into PG9 produced a chimeric antibody with enhanced HIV-1 neutralization. Although HIV-1-glycan diversity facilitates evasion, antibody somatic diversity can overcome this and can provide clues to guide the design of modified antibodies with enhanced neutralization.",
author = "Marie Pancera and Syed Shahzad-Ul-Hussan and Doria-Rose, {Nicole A.} and McLellan, {Jason S.} and Bailer, {Robert T.} and Kaifan Dai and Sandra Loesgen and Louder, {Mark K.} and Staupe, {Ryan P.} and Yongping Yang and Baoshan Zhang and Robert Parks and Joshua Eudailey and Lloyd, {Krissey E.} and Julie Blinn and Alam, {S. Munir} and Haynes, {Barton F.} and Amin, {Mohammed N.} and Wang, {Lai Xi} and Burton, {Dennis R.} and Koff, {Wayne C.} and Nabel, {Gary J.} and Mascola, {John R.} and Bewley, {Carole A.} and Kwong, {Peter D.}",
year = "2013",
month = "7",
doi = "10.1038/nsmb.2600",
language = "English (US)",
volume = "20",
pages = "804--813",
journal = "Nature Structural and Molecular Biology",
issn = "1545-9993",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16

AU - Pancera, Marie

AU - Shahzad-Ul-Hussan, Syed

AU - Doria-Rose, Nicole A.

AU - McLellan, Jason S.

AU - Bailer, Robert T.

AU - Dai, Kaifan

AU - Loesgen, Sandra

AU - Louder, Mark K.

AU - Staupe, Ryan P.

AU - Yang, Yongping

AU - Zhang, Baoshan

AU - Parks, Robert

AU - Eudailey, Joshua

AU - Lloyd, Krissey E.

AU - Blinn, Julie

AU - Alam, S. Munir

AU - Haynes, Barton F.

AU - Amin, Mohammed N.

AU - Wang, Lai Xi

AU - Burton, Dennis R.

AU - Koff, Wayne C.

AU - Nabel, Gary J.

AU - Mascola, John R.

AU - Bewley, Carole A.

AU - Kwong, Peter D.

PY - 2013/7

Y1 - 2013/7

N2 - HIV-1 uses a diverse N-linked-glycan shield to evade recognition by antibody. Select human antibodies, such as the clonally related PG9 and PG16, recognize glycopeptide epitopes in the HIV-1 V1-V2 region and penetrate this shield, but their ability to accommodate diverse glycans is unclear. Here we report the structure of antibody PG16 bound to a scaffolded V1-V2, showing an epitope comprising both high mannose-type and complex-type N-linked glycans. We combined structure, NMR and mutagenesis analyses to characterize glycan recognition by PG9 and PG16. Three PG16-specific residues, arginine, serine and histidine (RSH), were critical for binding sialic acid on complex-type glycans, and introduction of these residues into PG9 produced a chimeric antibody with enhanced HIV-1 neutralization. Although HIV-1-glycan diversity facilitates evasion, antibody somatic diversity can overcome this and can provide clues to guide the design of modified antibodies with enhanced neutralization.

AB - HIV-1 uses a diverse N-linked-glycan shield to evade recognition by antibody. Select human antibodies, such as the clonally related PG9 and PG16, recognize glycopeptide epitopes in the HIV-1 V1-V2 region and penetrate this shield, but their ability to accommodate diverse glycans is unclear. Here we report the structure of antibody PG16 bound to a scaffolded V1-V2, showing an epitope comprising both high mannose-type and complex-type N-linked glycans. We combined structure, NMR and mutagenesis analyses to characterize glycan recognition by PG9 and PG16. Three PG16-specific residues, arginine, serine and histidine (RSH), were critical for binding sialic acid on complex-type glycans, and introduction of these residues into PG9 produced a chimeric antibody with enhanced HIV-1 neutralization. Although HIV-1-glycan diversity facilitates evasion, antibody somatic diversity can overcome this and can provide clues to guide the design of modified antibodies with enhanced neutralization.

UR - http://www.scopus.com/inward/record.url?scp=84880149399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880149399&partnerID=8YFLogxK

U2 - 10.1038/nsmb.2600

DO - 10.1038/nsmb.2600

M3 - Article

C2 - 23708607

AN - SCOPUS:84880149399

VL - 20

SP - 804

EP - 813

JO - Nature Structural and Molecular Biology

JF - Nature Structural and Molecular Biology

SN - 1545-9993

IS - 7

ER -